Abstract. Photodynamic therapy (PDT) is currently being used as an alternative therapeutic modality for a variety of malignant tumors. This study was performed to show an efficient preparation of second generation of photosensitizer chlorin e 6 (Ce 6 ) with high yield and purity, and to test antitumor activity of Ce 6 -induced PDT (Ce 6 -PDT) both in vitro and in vivo using a rat tumor model. Three-week-old male Sprague-Dawley (SD) rats were inoculated s.c. on the right flank with 5x10 6 RK3E-ras cells. The animals were administered i.v. with Ce 6 (10 mg/kg) and 24 h later, PDT was performed using a laser diode at a light dose of 100 J/cm 2 . Ce 6 -PDT generated reactive oxygen species and led to significant growth inhibition in RK3E-ras cell. In addition, Ce 6 -PDT induced apoptosis through the activation of caspase-3 and its downstream target, PARP cleavage. The protein level of antiapoptotic bcl-2 was also reduced by Ce 6 -PDT in RK3E-ras cells. In in vivo experiments, application of Ce 6 -PDT led to a significant reduction of tumor size. PCNA immunostaining and TUNEL assay revealed that Ce 6 -PDT inhibited tumor cell proliferation and increased apoptosis. These findings suggest that the newly purified Ce 6 -PDT can effectively arrest tumor growth by inhibiting cell proliferation and inducing apoptosis.
Introduction
Photodynamic therapy (PDT) is currently being used as a therapeutic alternative for a variety of malignant tumors. Compared with ionizing radiation therapy or chemotherapy, PDT is generally safer for the surrounding normal tissues because photosensitizers are preferentially accumulated in tumor cells (1) . PDT involves the selective uptake and retention of a photosensitizer in the tumor followed by light irradiation of an appropriate wavelength to cause the destruction of tumor cells by the formation of cytotoxic reactive oxygen species (ROS) (1, 2) . The type I radicals including superoxide anion (O 2
• ), hydrogen peroxide (H 2 O 2 ), hydroxyl radical ( • OH), and type II ROS such as singlet oxygen have been implicated in the therapeutic or toxic responses of PDT (3) . PDT produces cytotoxic effects through photodamage to subcellular organelles and molecules such as mitochondria, lysosomes, cell membranes, and nuclei of tumor cells, which are considered as potential targets. During light exposure, photosensitizers that are localized in mitochondria may induce apoptosis, while those localized in lysosomes and cell membranes may cause necrosis. Apoptosis is responsible for PDT-mediated tumor cell death in vitro and tumor ablation in vivo (2, 4) .
In clinical PDT, photosensitizers such as hematoporphyrin derivatives, Photofrin, Photosens, Levulan and Visudyne have been used exclusively. These compounds have low localization in tumors, resulting in low photodynamic effect and high skin photosensitivity (2, 5) . Therefore, development of compounds with higher selective affinity for tumors was required and consequently, chlorin e 6 (Ce 6 ) was developed as a second generation photosensitizer. It is a promising photosensitizer as it exhibits advantageous photophysical properties for PDT such as having long lifetimes in their photoexcited triplet states and high molar absorption in the red region of the visible spectrum. Moreover, a 664-nm laser light can penetrate tissue deeper that the 630-nm laser light used for Photofrin (6) . However, a mixed form of Ce 6 derivatives has been prepared in the clinical application (7, 8) . Therefore, a standard process for the preparation of pure form of Ce 6 with high yield is required.
In this study, we developed an efficient preparation of Ce 6 with high yield and purity from chlorophyll a of a seawater live chlorella (Chlorella ellipsoidea) belonging to green algae. We investigated anticancer effect of PDT with the newly isolated Ce 6 through both in vitro and in vivo experiments.
Materials and methods
Preparation of chlorin e 6 . Live chlorella (Chlorella ellipsoidea) 100 g (dried weight) was sequentially washed with 500 ml of water and 300 ml of 50% ethanol in water to remove polar materials and the residue was extracted twice with 500 ml of 100% ethanol to obtain chlorophyll a rich fraction (extraction yield 4.3%). Stirring the combined ethanol solution of chlorophyll a in 1 N HCl (pH 2.5) for 3 h at room temperature afforded pheophytin in the form of precipitates. The precipitate was dissolved in dichloromethane washed with distilled water, dried with anhydrous sodium sulfate, and rotary-evaporated to dryness. The residue was purified by a chromatography using neutral alumina (Aldrich, Brockmann, ~150 mesh) with a gradient elution from 30% dichloromethane in n-hexane to 100% dichloromethane. The main green band was collected and evaporated to dryness. The crystalline powder was dissolved in acetone, adjusted pH 12.0 with 1 N NaOH, and stirred for 12 h. The precipitated Ce 6 was filtered, washed with acetone and dissolved in 100 ml of water, and filtered to remove insoluble impurity. After lyophilization of the filtered water solution, a fine black powder of Ce 6 was obtained. The purity of Ce 6 is 93-98% (yield of Ce 6 : 1% from dried weight of chlorella).
Cell culture. RK3E-ras cells, rat kidney epithelial cells transformed with K-ras gene, were maintained in DMEM medium containing 5% fetal bovine serum, 100 U/ml penicillinstreptomycin (Invitrogen, CA, USA) and subsequently incubated at 37˚C in an atmosphere containing 5% CO 2 . RK3E-ras cells were kindly provided by Dr Eric Fearon (University of Michigan Medical School, Ann Arbor, MI) and were described previously (9) .
In vitro photodynamic treatment. RK3E-ras cells (2x10 4 cells/ well) were cultured overnight in 12-well plates and treated with different doses of Ce 6 for 24 h. Subsequently, PDT was performed using a laser diode (Geumgwang Co., Ltd., Daejeon, Korea) at a wavelength of 664 nm. The total laser energy density was 10 J/cm 2 .
MTT assay. After Ce 6 -PDT, the viability of RK3E-ras cells was assessed by MTT assay. Each well was washed twice with PBS, and 0.5 ml of cell culture medium and 50 μl of 3-(4,5-dimethylthiazol-2-yl)-3-5-diphenyltetrazolium bromide solution (5 mg/ml in PBS) were added. After 3 h of incubation, medium was removed and 250 μl of acidisopropanol (0.04 mol/l HCl in isopropanol) was added. The absorbance was measured at 595 nm of microplate autoreader ELISA (Bio-Tek Instruments Inc., Winooski, VT) and all experiments were performed in triplicate.
ROS assay. After Ce 6 -PDT, the cells were washed twice with PBS and incubated in medium containing 10 μM of Flow cytometry. At 24 h after Ce 6 -PDT, 1x10
6 RK3E-ras cells were stained to the Vybrant ® apoptosis assay kit (Molecular Proves), followed by labeling Alexa Fluor ® 488 Annexin V and propidium iodide. Cells (10,000) per sample were analyzed immediately using Cell Llab Quanta™ SC flow cytometer (Beckman Coulter Inc., Miami, FL) and software.
Measurement of caspase-3 activity. Activity of caspase-3 in the cells with Ce 6 -PDT was measured using ApoAlert Caspase colorimetric assay kit according to the manufacturer's instructions (Clontech Laboratories, Mountain View, CA). The absorbance of the solution was measured at 405 nm using Microplate Autoreader ELISA (Bio-Tek Instruments Inc., Winooski, VT) and all experiments were performed in triplicate.
Western blotting. At 24 h after Ce 6 -PDT, the cells were lysed in 1X reporter lysis buffer (Promega, Madison, WI). The total protein was resolved by 12% SDS-PAGE and transferred onto PVDF membranes. After blocking in TBS-T (20 mmol/l Tris, 137 mmol/l NaCl, 1 g/l Tween-20, pH 7.6) with 5% skim milk for 4 h at room temperature, the membranes were incubated with primary antibodies against cleaved PARP (Cell Signaling Technology, Beverly, MA), bcl-2, and actin (Santa Cruz Biotechnology, Santa Cruz, CA) for 2 h. The membranes were then washed 3 times with TBS-T and incubated with secondary antibodies for 1 h at room temperature. Finally, the membranes were visualized using the ECL detection reagent.
In vivo experiment. RK3E-ras-Fluc cells were used for in vivo experiment, which was previously established in our laboratory (10) . Three-week-old male SD rats (Samtaco, Osan, South Korea) were inoculated s.c. on the right flank with 5x10 6 of RK3E-ras-Fluc cells. One week later, by which time the tumors had reached ~0.7-1.0 cm in diameter, the animals were administered i.v. with Ce 6 at a dosage of 10 mg/kg. After 24 h, PDT was performed using a laser diode at a light dose of 100 J/cm 2 and wavelength of 664 nm. The animals were monitored daily and tumor volume was measured by caliper and calculated by the formula as previously described (11): V=(ab 2 )/2, in which a is the longest diameter and b is the shortest diameter of the tumor. All experiments were performed under protocols approved by the Animal Care and Use Committee at Chosun University School of Dentistry.
Imaging. Radiographs were performed using a soft X-ray apparatus (Softex Model CMBW-2, Tokyo, Japan) with exposure of 30 sec with 25 kV and 20 mA conditions as previously described (10) .
For bioluminescence imaging, the animals were anesthetized with the combination of ketamine (50 mg/kg) and xylazine (5 mg/kg) and then given i.p. with luciferin (Molecular Probes, Palo Alto, CA) at a dose of 80 mg/kg body. The animals were imaged with the Xenogen IVIS imaging system (Xenogen Co., Alameda, CA) to record the bioluminescent signal emitted from the tumor. The IVIS-100 equipped with CCD camera system was used for emitted light acquisition, and Living Image software (Xenogen) was used for data analysis.
Histopathology, immunohistochemistry, and TUNEL assay.
The animals were sacrificed on day 15 and the tumors were removed carefully and fixed in 10% formalin over 24 h. The tissues were then dehydrated in an alcohol-xylene series and embedded in paraffin wax. From each block, sections 2 μm thick were prepared and stained with haematoxylin and eosin for histological examination. For immunohistochemistry, the sections were incubated in 3% H 2 O 2 in methanol for 10 min to remove endogenous peroxidase and blocked with 1% BSA in PBS for 1 h. The sections were then incubated with anti-PCNA antibody (Dako) overnight at 4˚C. After washed 3 times with PBS-T, the sections were subjected to avidin-biotin peroxidase complex (ABC) method (Vector) and peroxidase activity was evaluated with 3,3'-diaminobenzidine (Vector). Finally, the sections were counterstained with hematoxylin. The PCNA-positive cells were counted from 5 randomly selected areas under x200 magnifications and represented as mean ± SD.
The terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) assay was done using an Apoptosis detection kit (Intergen, Purchase, NY) according to the manufacturer's protocol.
Statistical analysis. The differences in mean values among groups were tested, and the values were expressed as mean ± SD. All of the statistical calculations were carried out using Microsoft Excel.
Results and Discussion
The yield of chlorophyll a extracted from undisrupted chlorella cells with ethanol was 10 times more than that from a commercially available chlorella powder (data not shown). The retention time of chlorophyll a in HPLC system was 7.8 min (Fig. 1A) . Treatment of the ethanol to chlorophyll a in an acidic condition (1 N HCl, pH 2.5) enable to remove the Mg 2+ ion easily to afford a crude pheophytin in the form of precipitates, which could be further purified with alumina column chromatography (Fig. 1B) . As the final step, pheophytin was hydrolized by reacting with 1 N NaOH (pH 12.0) to give Ce 6 as a fine powder which is a water soluble sodium salt form with 95-98% purity (Fig. 1C) . The molecular weight of Ce 6 (596.2) was confirmed by an observation of 597.2 in LC-MS analysis as the (M+H) + form (Fig. 1D) . The total yield of Ce 6 is 1%, based on the calculation as a percentage of obtained Ce 6 weights to the dried weight of chlorella. In this study, we established an efficient isolated procedure of highly pure Ce 6 utilizing undisrupted live chlorella, a key rich source of the starting material chlorophyll a. The cytotoxic effect of PDT on the survival of Ce 6 -treated cells was examined in a time-and dose-dependent manner using MTT assays. The viability of RK3E-ras cells was decreased by Ce 6 -PDT depending on Ce 6 concentration ( Fig. 2A) . When Ce 6 was treated for 12 and 24 h, PDT most effectively reduced cell viability (Fig. 2B) . The excited photosensitizer interacts with molecular oxygen and results in the production of ROS, which can lead to damage of the cellular constituents and subsequent cell destruction (12) (13) (14) . It is believed that ROS plays a direct role in damaging cells subjected to PDT (2, 4) . Therefore, we examined intracellular ROS production by Ce 6 -PDT in the RK3E-ras cells. ROS generation was induced immediately after Ce 6 -PDT and increased in a time-dependent manner (Fig. 2C) .
Apoptosis is responsible for PDT-mediated tumor inhibition in certain cell lines (15, 16) . To examine whether the growthinhibitory effect of Ce 6 -PDT in RK3E-ras cells is caused by apoptosis, flow cytometry was performed 24 h after Ce 6 -PDT. Among Ce 6 -PDT-treated cells, 51.5% cells were shown to be apoptotic and 39.71% is necrotic or late apoptotic (Fig. 3A) .
Although cell death can be induced by PDT with different photosensitizers, the molecular characteristics involved in each death event might be different (14, 17) . To examine the molecular changes associated with cell death in RK3E-ras cells by Ce 6 -PDT, we investigated caspase-3 activity, which is a hallmark of apotosis. Ce 6 -PDT enhanced caspase-3 activity in a time-dependent manner (Fig. 3B) , implicating that Ce 6 -PDT triggers caspase-3 activation in RK3E-ras cells. Particularly, 12 h after PDT, caspase-3 activity showed an 88.6% increase compared with those in control group.
Caspase-3 plays an important role in the execution of apoptosis and is primarily responsible for the cleavage of PARP during cell death (18) (19) (20) (21) (22) . The activation of PARP by DNA strand breaks contributes to the consumption of NAD and ATP that occurs in cells undergoing apoptosis (23, 24) . In this study, the cleavage of PARP was detected in Rk3E-ras cells 12 and 24 h after Ce 6 -PDT (Fig. 3C ). Moreover, the protein level of anti-apoptotic bcl-2 was reduced 24 h after Ce 6 -PDT (Fig. 3C) . These findings suggest that Ce 6 -PDT might induce growth inhibition in RK3E-ras cells through apoptosis.
We previously demonstrated an animal model for rapid induction of malignant tumor (25) . This animal model has the advantage of allowing short-term screening of antitumor agents. We examined the effect of Ce 6 -PDT on in vivo tumor growth using this rat model with subcutaneous injection of RK3E-ras cells. Tumor volume was measured every three days after Ce 6 -PDT and the results showed that Ce 6 -PDT treatment arrested tumor progression (Fig. 4A) . On gross, Softex X-ray, and bioluminescence images, the tumor almost disappeared in the rats treated with Ce 6 -PDT (Fig. 4B) . These results suggest that only a single application of Ce 6 (Fig. 5A, top) . Most of tumor cells in the control and treated with Ce 6 or laser alone were PCNA-positive, suggesting a high proliferative rate. However, the number of PCNA-positive cells significantly decreased in tumor treated with Ce 6 -PDT (Fig. 5A and B) . We also performed TUNEL staining to assess the amount of the apoptotic cells in vivo. TUNEL-positive cells significantly increased in tumor treated with Ce 6 -PDT compared with the control untreated ( Fig. 5A and C) . These results confirmed in vitro data that Ce 6 -PDT effectively arrested the tumor growth by inhibiting cell proliferation and inducing apoptosis.
In summary, we showed herein that PDT using newly purified second-generation photosensitizer Ce 6 exerted cytotoxic effect via the intracellular ROS production on the RK3E-ras cell line that induces rapid malignant tumor growth in SD rats. Ce 6 -PDT also induced apoptosis through the activation of caspase-3, and its downstream target, PARP cleavage. In addition, Ce 6 -PDT effectively arrested the tumor growth by inhibiting cell proliferation and inducing apoptosis. Therefore, the present study suggests that the newly purified Ce 6 -PDT may be useful in the clinical application to control solid tumors. 
